Jun Pang

ORCID: 0000-0003-0024-9415
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Nanoplatforms for cancer theranostics
  • Cancer, Lipids, and Metabolism
  • Nanoparticle-Based Drug Delivery
  • Urologic and reproductive health conditions
  • RNA Interference and Gene Delivery
  • Bladder and Urothelial Cancer Treatments
  • Epigenetics and DNA Methylation
  • Ferroptosis and cancer prognosis
  • Cancer, Hypoxia, and Metabolism
  • Hormonal and reproductive studies
  • Cancer-related gene regulation
  • Renal cell carcinoma treatment
  • Dendrimers and Hyperbranched Polymers
  • Immunotherapy and Immune Responses
  • Minimally Invasive Surgical Techniques
  • Cancer Immunotherapy and Biomarkers
  • Angiogenesis and VEGF in Cancer
  • Immune Cell Function and Interaction
  • Cancer-related molecular mechanisms research
  • Pelvic floor disorders treatments
  • Microtubule and mitosis dynamics
  • Radiopharmaceutical Chemistry and Applications
  • Ubiquitin and proteasome pathways

Sun Yat-sen University
2016-2025

The Seventh Affiliated Hospital of Sun Yat-sen University
2018-2025

Shanghai Jiao Tong University
2025

Youjiang Medical College for Nationalities
2024

North Sichuan Medical University
2018-2020

Nanchong Central Hospital
2020

Education University of Hong Kong
2020

Dalian Medical University
2019-2020

Second Affiliated Hospital of Chongqing Medical University
2019-2020

Chongqing Medical University
2019-2020

Background Risk and crisis communication plays an essential role in public health emergency responses. The COVID-19 pandemic has triggered spontaneous intensive media attention, which affected people’s adoption of personal preventive measures their mental health. Objective aim this study was to investigate the associations between exposure COVID-19–specific information (depression sleep quality) self-reported compliance with (face mask wearing hand sanitizing). We also tested whether these...

10.2196/22596 article EN cc-by Journal of Medical Internet Research 2020-09-16

Clear cell renal carcinoma (ccRCC) is one of the most common malignancies urinary system. Patient outcomes are relatively poor due to lack early diagnostic markers and resistance existing treatment options. Programmed death, also known as apoptosis, a highly regulated orchestrated form death that occurs ubiquitously throughout various physiological processes. It plays crucial role in maintaining homeostasis balance cellular activities. The combination immune checkpoint inhibitors plus...

10.1038/s41420-024-01880-0 article EN cc-by Cell Death Discovery 2024-03-05

Association of cigarette use with risk prostate cancer remains unclear. We performed this study to examine whether is associated increased cancer. This cross-sectional used data from the 1999 2020 National Health and Nutrition Examination Survey (NHANES), a population-based nationally representative survey designed assess health nutritional status US adults children. Males were eligible if they aged ≥ 20 years at time participation. Cigarette (ever use, categorized into former current use)...

10.1186/s12889-025-21863-9 article EN cc-by-nc-nd BMC Public Health 2025-02-13

Current predictive tools and imaging modalities are not accurate enough for preoperative diagnosis of lymph node metastatic prostate cancer (LNM PCa). Proteomic analysis is introduced to screen potential biomarkers early detection LNM PCa. In our initial study, protein samples from localized PCa as well benign prostatic hyperplasia tissues were analyzed using two-dimensional fluorescence difference in gel electrophoresis (2-D DIGE) coupled with MALDI-TOF/TOF MS. We identified 58 proteins...

10.1021/pr900953s article EN Journal of Proteome Research 2009-11-07

Incidence and mortality of prostate cancer (PCa) rank in the top five among male tumors. However, single treatment modalities are often restricted due to biochemical recurrence drug resistance, necessitating development new approaches for combination castration-resistant neuroendocrine PCa. Ferroptosis is characterized by accumulation iron-overload-mediated lipid peroxidation has shown promising outcomes anticancer treatment, prompting us present a review reporting application ferroptosis...

10.1039/d3bm01894f article EN Biomaterials Science 2024-01-01

Abstract Abnormal lipid metabolism and accumulation are characteristic hallmarks of renal cell carcinoma (RCC). While there is prior evidence closely linking such within RCC cells consequent tumorigenesis, the mechanisms underlying this process remain incompletely understood. In study, a series bioinformatics analyses were initially performed by screening databases gene sets, ultimately leading to identification TRIB3 as an oncogene that functions central regulator metabolism. overexpression...

10.1038/s41419-024-06627-4 article EN cc-by Cell Death and Disease 2024-04-01

We would like to express our thanks and appreciation the individuals who participated in NHANES staff made this research possible.

10.18332/tid/201399 article EN cc-by Tobacco Induced Diseases 2025-03-07

Schematic illustration of the development long-circulating pH-responsive polysaccharide–DOX prodrug nanoparticles for antitumor applications.

10.1039/c8tb02474j article EN Journal of Materials Chemistry B 2018-11-29

Abstract Multifactor and multistep processes were elucidated to participate in the progression of non‐small‐cell lung cancer (NSCLC). Circular RNA 0031250 (circ‐PRMT5) was a vital factor NSCLC. However, role circ‐PRMT5 cisplatin (DDP)‐resistance needed be further highlighted. Expression profiles circ‐PRMT5, microRNA (miR)‐4458, EV3‐like DNA‐directed polymerase ζ catalytic subunit (REV3L) detected using quantitative real‐time chain reaction....

10.1002/cbin.11449 article EN Cell Biology International 2020-08-27

Abstract Androgen receptor (AR) signaling inhibitors provide limited survival benefits to patients with prostate cancer (PCa), and worse, few feasible genomic lesions restrict targeted treatment PCa. Thus, a better understanding of the critical dependencies PCa may enable more therapeutic approaches dilemma. We performed kinome-scale CRISPR/Cas9 screen identified cyclin-dependent kinase 12 (CDK12) as being conservatively required for cell survival. Suppression CDK12 by covalent inhibitor...

10.1038/s41419-021-04027-6 article EN cc-by Cell Death and Disease 2021-07-27

Metabolic dysfunction is seen in cancer cells where increased glycolysis provides energy for growth. Circular RNAs (circRNAs) are thought to assist glucose metabolism and the switch glycolysis. Through screening, we found that circVAMP3 was necessary both glycolytic proliferative activities renal cell carcinoma (RCC). Furthermore, expression elevated RCC patients correspondence with TNM stage. Mechanistically, observed interact directly lactate dehydrogenase A (LDHA) modulate its activity....

10.1038/s41419-022-04863-0 article EN cc-by Cell Death and Disease 2022-05-07

Combination therapy has emerged as a promising approach for treating tumors, although there is room improvement. This study introduced novel strategy that combined the enhancement of apoptosis, ferroptosis, and DNA damage to improve therapeutic outcomes prostate cancer. Specifically, we have developed supramolecular oxidative stress nanoamplifier, which was comprised β-cyclodextrin, paclitaxel, ferrocene-poly(ethylene glycol). Paclitaxel within system disrupted microtubule dynamics, inducing...

10.1021/acs.biomac.4c00260 article EN Biomacromolecules 2024-05-23

// Ke Li 1, * , Jun Pang Huaiyan Cheng 2, Wei-Peng Liu 3 Jin-Ming Di 1 Heng-Jun Xiao Yun Luo Hao Zhang Wen-Tao Huang Ming-Kun Chen Liao-Yuan Chun-Kui Shao 4 Ying-Hong Feng 2 Xin Gao Department of Urology, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China Pharmacology, Uniformed Services University Health Sciences, Bethesda MD20814, USA First Hospital Nan Chang Nanchang 330006, Pathology, These authors have contributed equally to this work Correspondence to: Gao,...

10.18632/oncotarget.3192 article EN Oncotarget 2015-04-09
Coming Soon ...